Live Vital sells protocols, not vials. Nine of them, each a named compound or blend at a monthly rate, with a physician named on the site and a pharmacy that is not.

The first tesamorelin figure in this catalogue

Tesamorelin has been the thinnest column here. One seller carries it and publishes no price, which means the page for it has shown a name and an empty cell since it launched. Live Vital’s $166 a month is the first number that column has had.

It comes with a caveat large enough to state twice: there is no strength against it. A seller who prices by the milligram lists tesamorelin at $100 for a 15mg vial. Whether $166 a month is better or worse than that is not a question the site lets you answer.

Ten weeks, billed monthly

Their pricing page gives a range — $99 to $299 a month — and a protocol length of ten weeks. Those two facts do not divide into each other. Two monthly payments cover about eight and a half weeks of a ten-week course; a third overshoots it. Nothing on the site says what the eleventh week costs, or whether the protocol renews, tapers or simply ends.

That is not a hidden fee. It is an unanswered question, and it is the one worth asking first.

One half of the supply chain

Dr. Patrick Taylor, MD, is named as the physician behind the protocols — family medicine and longevity, Salt Lake City. That is more than most sellers here offer.

The pharmacy is not named at all: “a licensed US compounding pharmacy.” Which matters more than it sounds, because the site also claims all fifty states, and it is the pharmacy’s non-resident licence that decides whether a compounded prescription can cross a state line. The clinician half of that claim is checkable in principle. The pharmacy half is not checkable at all from what is published.

What is not here

Our own market survey in August recorded Live Vital as the first telehealth programme to put retatrutide on a public menu. It is not on their treatments page now. We are not carrying it on the strength of our own note, and we are not claiming they withdrew it either — only that it is not there today.